Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Teva pharmaceutical industries ltd save search
Smart Inhaler Technology Market size to grow by USD 46.37 million from 2022-2027, North America to account for 37% of market growth - Technavio
Published: 2023-12-01 (Crawled : 00:20) - prnewswire.com
NVSEF | $97.95 1.48% 2.98% 100
|
Health Technology
| Email alert
Add to watchlist
RMD | $159.64 1.21% 0.0% 700K
|
Health Technology
| Email alert
Add to watchlist
AZN | $64.79 0.31% 0.03% 3.6M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $125.0 -2.72% 8.8% 3.4K
|
Health Technology
| Email alert
Add to watchlist
NVS | $98.13 0.24% -0.16% 1.2M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $8.5 5.21% 100
|
Health Technology
| Email alert
Add to watchlist
IFNNF | $38.3 -3.99% -13.37% 11K
|
Electronic Technology
| Email alert
Add to watchlist
RSMDF S | $ 0%
|
Health Technology
| Email alert
Add to watchlist
IFNNY | $39.38 1.76% 0.0% 110K
|
Manufacturing
| Email alert
Add to watchlist
america smart technology growth market
Laryngeal Cancer Therapeutics Market size to grow by USD 575.25 million from 2022-2027| Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc. and more among the major companies in the market- Technavio
Published: 2023-12-01 (Crawled : 23:00) - prnewswire.com
SNY | $46.72 -0.06% 0.06% 1.2M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $8.5 5.21% 100
|
Health Technology
| Email alert
Add to watchlist
SNYNF | $94.0 1.34% 1.34% 860
|
Health Technology
| Email alert
Add to watchlist
AZN | $64.79 0.31% 0.03% 3.6M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $125.0 -2.72% 8.8% 3.4K
|
Health Technology
| Email alert
Add to watchlist
AMGN G | $272.45 1.04% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
companies astrazeneca cancer therapeutics market
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
SNYNF | $94.0 1.34% 1.34% 860
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
TEVA | $9.71 -1.12% 0.0% 6.6M
|
Health Technology
|
| O: -0.52%
H: 3.73%
C: 1.87%
SNY | $46.72 -0.06% 0.06% 1.2M
|
Health Technology
|
| O: -1.09%
H: 0.0%
C: 0.0%
disease treatment collaboration teva deal
Pulmonary Arterial Hypertension Market Size Valuation Will Exceed USD 11.35 Billion By 2032, at 5.0% CAGR: Polaris Market Research
Published: 2023-11-29 (Crawled : 15:30) - prnewswire.com
VTRS | $9.37 2.07% 0.0% 7.4M
|
Health Technology
|
| O: 0.11%
H: 0.44%
C: -0.22%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
UTHR | $240.73 0.3% 0.0% 310K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
GILD | $77.65 1.37% -0.05% 5.4M
|
Health Technology
|
| O: 0.46%
H: 0.8%
C: 0.51%
research hypertension market
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
Published: 2023-11-29 (Crawled : 09:00) - globenewswire.com
ALVO | $9.45 -0.53% -0.42% 180K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -5.05%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
KMDA | $4.65 -1.69% 0.0% 9.6K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
avt05 simponi biosimilar positive results study
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $9.45 -0.53% -0.42% 180K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -5.05%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $143.41 0.72% -0.11% 4.9M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $4.65 -1.69% 0.0% 9.6K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $9.45 -0.53% -0.42% 180K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -5.05%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $143.41 0.72% -0.11% 4.9M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $4.65 -1.69% 0.0% 9.6K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Open-Angle Glaucoma Therapeutics Market size to grow by USD 2.36 billion from 2022 to 2027, North America to account for 51% of market growth - Technavio
Published: 2023-11-28 (Crawled : 06:00) - prnewswire.com
NVS | $98.13 0.24% -0.16% 1.2M
|
Health Technology
|
| O: -0.74%
H: 0.08%
C: -0.22%
BHC | $7.36 3.08% 0.0% 1.8M
|
Health Technology
|
| O: 1.48%
H: 1.17%
C: 0.29%
ALC | $75.85 0.29% 0.0% 970K
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
ABBV | $143.41 0.72% -0.11% 4.9M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
america glaucoma therapeutics growth market
Global Glioma Treatment Market Research Report 2023: Breakthrough Oncolytic Virus Therapy Offers New Hope for Glioma Patients - Forecast to 2027 and 2032
Published: 2023-11-27 (Crawled : 23:00) - prnewswire.com
TMO | $496.13 0.08% 0.0% 1.2M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
KPTI | $0.7908 2.7% -0.1% 1.8M
|
Health Technology
|
| O: 4.0%
H: 1.93%
C: -7.72%
AMGN G | $272.45 1.04% 0.0% 2.3M
|
Health Technology
|
| O: 0.03%
H: 0.85%
C: 0.44%
report hope treatment research global virus therapy market
Gonorrhea Therapeutics Market to grow by USD 506.68 million from 2022 to 2027; North America accounts for 39% of market growth - Technavio
Published: 2023-11-21 (Crawled : 20:00) - prnewswire.com
GLAXF | $18.25 5.74% -0.49% 3.8K
|
Health Technology
|
| O: -3.23%
H: 0.0%
C: -0.35%
GSK | $36.57 1.61% -0.06% 2.5M
|
Health Technology
|
| O: -0.23%
H: 0.2%
C: -0.28%
america therapeutics growth market
Alvotech to Report Financial Results for the First Nine Months of 2023 on November 28, 2023, and Host Business Update Conference Call on November 29, 2023, at 8:00 am ET
Published: 2023-11-21 (Crawled : 13:00) - globenewswire.com
ALVO | $9.45 -0.53% -0.42% 180K
|
n/a
|
| O: -0.56%
H: 1.94%
C: 0.67%
KMDA | $4.65 -1.69% 0.0% 9.6K
|
Health Technology
|
| O: -0.21%
H: 1.06%
C: 0.85%
conference report business update financial results
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published: 2023-11-17 (Crawled : 16:00) - prnewswire.com
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
BMY P | $50.1 1.46% 0.08% 13M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
ABBV | $143.41 0.72% -0.11% 4.9M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
GILD | $77.65 1.37% -0.05% 5.4M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
reach research hiv market
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
Published: 2023-11-17 (Crawled : 16:00) - biospace.com/
TEVA | $9.71 -1.12% 0.0% 6.6M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
HALO | $39.69 2.8% 2.22% 1M
|
Health Technology
|
| O: 1.65%
H: 0.0%
C: 0.0%
forteo approval teva
Digital Dose Inhaler Market Set for Remarkable Growth, Estimated at $104.3 Billion by 2033
Published: 2023-11-16 (Crawled : 01:00) - prnewswire.com
GLAXF | $18.25 5.74% -0.49% 3.8K
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
AZNCF | $125.0 -2.72% 8.8% 3.4K
|
Health Technology
|
| O: -2.16%
H: 4.44%
C: 2.2%
GSK | $36.57 1.61% -0.06% 2.5M
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
MMM | $99.85 0.79% 0.04% 2.8M
|
Producer Manufacturing
|
| O: 0.25%
H: 0.0%
C: 0.0%
AZN | $64.79 0.31% 0.03% 3.6M
|
Health Technology
|
| O: -0.22%
H: 0.71%
C: 0.6%
set market
Global Epinephrine Markets, 2017-2022, 2022-2027F, 2032F: Product Innovation Drives Growth, Rising Prevalence of Chronic Respiratory Diseases Driving Demand
Published: 2023-11-14 (Crawled : 15:30) - prnewswire.com
VTRS | $9.37 2.07% 0.0% 7.4M
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: 0.0%
BHC | $7.36 3.08% 0.0% 1.8M
|
Health Technology
|
| O: 4.13%
H: 0.0%
C: 0.0%
ABT | $104.88 0.57% -0.01% 4.7M
|
Health Technology
|
| O: 0.94%
H: 0.0%
C: 0.0%
SNY | $46.72 -0.06% 0.06% 1.2M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
respiratory innovation global epinephrine
Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki (AVT04), the First Biosimilar of Stelara® (ustekinumab)
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
ALVO | $9.45 -0.53% -0.42% 180K
|
n/a
|
| O: -0.22%
H: 0.0%
C: 0.0%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
KMDA | $4.65 -1.69% 0.0% 9.6K
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
avt04 stelara pharma biosimilar authorization
Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program
Published: 2023-11-13 (Crawled : 13:30) - biospace.com/
TEVA | $9.71 -1.12% 0.0% 6.6M
|
Health Technology
|
| O: -2.38%
H: 4.53%
C: 2.56%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
RPRX | $27.35 1.03% 0.59% 4.5M
|
Health Technology
|
| O: -1.49%
H: 0.59%
C: 0.04%
pharma royalty teva program
Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
RPRX | $27.35 1.03% 0.59% 4.5M
|
Health Technology
|
| O: -1.49%
H: 0.59%
C: 0.04%
pharma royalty teva program
Challenges in Transparency and Control Hamper Merchant API Market Growth Despite Pharmaceutical Industry Expansion
Published: 2023-11-10 (Crawled : 00:20) - prnewswire.com
SNY | $46.72 -0.06% 0.06% 1.2M
|
Health Technology
| Email alert
Add to watchlist
LZAGY | $38.46 -0.41% 0.0% 110K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
SNYNF | $94.0 1.34% 1.34% 860
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $8.5 5.21% 100
|
Health Technology
| Email alert
Add to watchlist
LZAGF | $384.0 -1.03% -7.81% 960
|
Health Technology
| Email alert
Add to watchlist
TMO | $496.13 0.08% 0.0% 1.2M
|
Health Technology
| Email alert
Add to watchlist
control expansion growth market
STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara
Published: 2023-11-10 (Crawled : 14:30) - globenewswire.com
ALVO | $9.45 -0.53% -0.42% 180K
|
n/a
|
| O: 3.57%
H: 0.0%
C: 0.0%
biosimilar chmp positive stelara
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
ID 4 | $0.077 -9.41% 25.97% 420K
|
Finance
BKKT 4 | $1.88 25.33% 14.89% 4.8M
|
MGLD | $1.03 7.77% 14K
|
Manufacturing
CZOO | $0.4316 -6.52% 6.7% 65K
|
CCJ | $45.4 -1.13% 4.6% 3.9M
|
Non-Energy Minerals
AUMN | $0.562 0.34% 4.5% 360K
|
Non-Energy Minerals
SAIC 4 | $119.92 2.14% 4.24% 460K
|
Technology Services
CULP 4 | $5.06 -0.59% 3.95% 29K
|
Process Industries
LGL 4 | $4.94 1.23% 3.04% 15K
|
Electronic Technology
MPLN | $1.33 2.31% 3.01% 1.1M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.